Cargando…
TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer
Aberrant activation of beta-catenin/TCF (T-cell factor) signaling is frequently observed in the pancreatic cancer. However, the regulation of nuclear beta-catenin/TCF transcription machinery remains largely unknown. In this study, TFCP2 (transcriptional factor CP2) expression in pancreatic cancer wa...
Autores principales: | Yuedi, Dai, Yuankun, Cai, Jiaying, Zhao, Han, Liu, Yueqi, Wang, Houbao, Liu, Dexiang, Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642575/ https://www.ncbi.nlm.nih.gov/pubmed/29050300 http://dx.doi.org/10.18632/oncotarget.19741 |
Ejemplares similares
-
Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells
por: Dai, Yuedi, et al.
Publicado: (2016) -
TFCP2 Overcomes Senescence by Cooperating With SREBP2 to Activate Cholesterol Synthesis in Pancreatic Cancer
por: Zhang, Dexiang, et al.
Publicado: (2021) -
YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling
por: Jixiang, Chen, et al.
Publicado: (2017) -
CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma
por: Fan, Xin, et al.
Publicado: (2016) -
Neglected Functions of TFCP2/TFCP2L1/UBP1 Transcription Factors May Offer Valuable Insights into Their Mechanisms of Action
por: Taracha, Agnieszka, et al.
Publicado: (2018)